Aspects of complexity in quality and safety assessment of peptide therapeutics and peptide-related impurities. A regulatory perspective.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Aspects of complexity in quality and safety assessment of peptide therapeutics and peptide-related impurities. A regulatory perspective.
- Published In:
- Regulatory toxicology and pharmacology : RTP, 153, 105699 (2024)
- Authors:
- Colalto, Cristiano
- Database ID:
- RPEP-08021
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08021APA
Colalto, Cristiano. (2024). Aspects of complexity in quality and safety assessment of peptide therapeutics and peptide-related impurities. A regulatory perspective.. Regulatory toxicology and pharmacology : RTP, 153, 105699. https://doi.org/10.1016/j.yrtph.2024.105699
MLA
Colalto, Cristiano. "Aspects of complexity in quality and safety assessment of peptide therapeutics and peptide-related impurities. A regulatory perspective.." Regulatory toxicology and pharmacology : RTP, 2024. https://doi.org/10.1016/j.yrtph.2024.105699
RethinkPeptides
RethinkPeptides Research Database. "Aspects of complexity in quality and safety assessment of pe..." RPEP-08021. Retrieved from https://rethinkpeptides.com/research/colalto-2024-aspects-of-complexity-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.